Access cutting-edge obesity treatment through this clinical trial at a research site in Huntsville. Study-provided care at no cost to qualified participants.
Access obesity specialists in Huntsville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related obesity treatment provided free
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m\^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.
Sponsor: Eli Lilly and Company
Check if you qualify for this obesity clinical trial in Huntsville, AL
If you're searching for obesity treatment options in Huntsville, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Huntsville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.